• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Teva Pharmaceuticals

Teva Pharmaceuticals receives European approval for Spiromax inhalers

April 8, 2021 By Sean Whooley Leave a Comment

Teva Pharmaceuticals announced today that it received European marketing authorization for its Seffalair and BroPair Spiromax inhalers. Seffalair Spiromax and its duplicate BroPair Spiromax (salmeterol xinafoate/ fluticasone propionate, 12.75/100 and 12.75/202 micrograms delivered doses) received approval as a maintenance treatment for asthma in adults and adolescents aged 12 years and older, according to a news release. […]

Filed Under: Business/Financial News, Drug-Device Combinations, Pharmaceutical, Regulatory/Compliance, Respiratory Tagged With: Teva Pharmaceuticals

8 drug delivery innovations you need to know

February 25, 2021 By Sean Whooley

The drug delivery space has seen plenty of innovation over the years and there are no signs of that slowing down any time soon. Improvements upon established technologies like insulin delivery devices and inhalers have been presented by some, while others have unlocked new ways of delivering drugs through a variety of means. Among the […]

Filed Under: Business/Financial News, Drug Pumps, Drug-Device Combinations, Featured, Pharmaceutical Tagged With: dyvebioscience, Enable Injections, evoxtherapeutics, Inovio Pharmaceuticals, Johns Hopkins, Lyra Therapeutics, Medtronic, Tandem Diabetes Care, Teva Pharmaceuticals, Teva Respiratory

Amazon, Onica to support digital health for Teva’s Digihaler

October 22, 2020 By Sean Whooley

Teva Respiratory (NYSE:TEVA) announced that it is collaborating with Amazon Web Services (AWS) and Onica to build and host its digital health platform. The Teva Pharmaceuticals affiliate’s digital health platform is a cloud-based backend data system designed to support its FDA-approved Digihaler portfolio of breath-actuated digital inhalers and its companion mobile app that tracks inhaler events […]

Filed Under: Digital Health, Drug-Device Combinations, Featured, Health Technology, Pharmaceutical, Respiratory Tagged With: Amazon, Onica, Teva Pharmaceuticals

MedTech 100 roundup: Stocks were practically unchanged last week

August 24, 2020 By Sean Whooley

Despite plenty of ups and downs coming in the stock market for the medtech industry, there was hardly any movement from week to week. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.6 points at the end of last week (Aug. 21). Overall, medtech stocks saw […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), Mergers & Acquisitions, Research & Development, Wall Street Beat Tagged With: Bayer, Cala Health, cochlear, conformis, CureVac, Fractyl Laboratories, Johnson and Johnson, momentapharmaceuticals, Principia Biopharma, S&P, Sanofi, Stryker, Teva Pharmaceuticals

Feds accuse Teva of $300M in kickbacks for MS drug

August 18, 2020 By Nancy Crotti

Massachusetts federal prosecutors today claimed that Teva Pharmaceuticals funneled $300 million from a pair of charitable foundations to subsidize Medicare copayments for a multiple sclerosis drug. Teva Pharmaceuticals and Teva Neuroscience, the maker of Copaxone, simultaneously raised the drug’s price by 329%, allegedly violating the Anti-Kickback Statute and False Claims Act, according to the complaint filed by the U.S. […]

Filed Under: Business/Financial News, Legal News, Pharmaceutical Tagged With: Teva Neuroscience, Teva Pharmaceuticals

The 18 most innovative medical devices of 2020

July 24, 2020 By Danielle Kirsh

The Galien Foundation recently announced nominees for most innovative medical devices for its 14th Annual Prix Galien USA Awards. The foundation bestows the Prix Galien Award annually to examples of outstanding biomedical and technology products that are designed to improve the human condition. “As we celebrate 50 years of the Prix Galien process, we are honored […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Endoscopic, Featured, Implants, Oncology, Pain Management, Patient Monitoring, Respiratory, Structural Heart, Vascular, Vision Tagged With: Abbott, BD, Biotronik, Boston Scientific, Edwards Lifesciences, endomag, Glaukos, Impulse Dynamics, Medtronic, Pear Therapeutics, Prix Galien USA, Pulmonx, Sonendo, Teva Pharmaceuticals

Teva launches connected inhaler for asthma, COPD

July 13, 2020 By Nancy Crotti

Teva (NYSE:TEVA) announced today that it has launched a Bluetooth-enabled version of its ProAir albuterol sulfate rescue inhaler. The ProAir Digihaler’s sensors connect to a companion mobile app to provide inhaler-use information to healthcare providers. The new inhaler is available by prescription to U.S. patients age 4 and older, according to the Tel Aviv, Israel-based company. […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceutical, Respiratory, Wall Street Beat Tagged With: Teva Pharmaceuticals

Teva launches generic EpiPen Jr.

August 20, 2019 By Sean Whooley

Teva (NYSE:TEVA) today announced that its FDA-approved generic EpiPen Jr. auto-injector is available in the U.S. The device wholesales to most retail pharmacies in packs of two for $300, or $150 per pen. Teva’s product is less than half the cost of Mylan’s non-generic EpiPen Jr., which lists at $643.89 per two-pack at Drugs.com. Get the full story at […]

Filed Under: Drug-Device Combinations, Pediatrics, Pharmaceutical Tagged With: Mylan, Teva Pharmaceuticals

The 17 most innovative medical devices of 2019

July 18, 2019 By Danielle Kirsh

The Galien Foundation recently announced nominees for most innovative medical devices for its 13th Annual Prix Galien USA Awards. The foundation awards the Prix Galien Award annually to examples of outstanding biomedical and technology product achievements that are designed to improve human condition. Nominees need to be FDA approved for market within the last five […]

Filed Under: Cardiac Implants, Cardiovascular, Drug-Device Combinations, Featured, Implants, Neuromodulation/Neurostimulation, News Well, Research & Development, Stents Tagged With: Abbott, Biotronik, Boston Scientific, Edwards Lifesciences, Endomagnetics, Glaukos, humanoptics, Lynch Biologics, Medtronic, Pear Therapeutics, Pulmonx, Sonendo, starkey, Teva Pharmaceuticals

Teva wins FDA approval for AirDuo Digihaler for asthma

July 16, 2019 By Danielle Kirsh

Teva (NYSE:TEVA) yesterday said that it received FDA approval for its AirDuo Digihaler Inhalation Powder. The Israel-based company’s AirDuo Digihaler is a combination therapy digital inhaler with built-in sensors that can connect to a smartphone application, indicated to treat asthma in people 12 years and older.. It delivers a multi-dose dry powder of 113mcg of fluticasone […]

Filed Under: Drug-Device Combinations, Food & Drug Administration (FDA), Respiratory Tagged With: Teva Pharmaceuticals

Teva wins EU nod for Ajovy migraine prophylactic

April 2, 2019 By Fink Densford

Teva (NYSE:TEVA) said yesterday that it won EC Marketing Authorization for its Ajovy pre-filled syringe injection meant to serve as a prophylaxis for migraines in adults who experience at least four migraine days per month. The Israel-based company said that Ajovy is a humanized monoclonal antibody that binds to the calcitonin gene-related peptide ligand and blocks […]

Filed Under: Neurological, Pharmaceutical, Regulatory/Compliance Tagged With: Teva Pharmaceuticals

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 7
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS